SOPHiA GENETICS SA (SOPH), Tuesday announced an expansion of collaboration with AstraZeneca (AZN), expecting to leverage its multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types of breast cancer.
Moreover, it will also support the potential development of a bespoke AI-powered predictive model aimed at optimizing outcomes for individuals undergoing treatment for breast cancer.
The expanded partnership is expected to position SOPHiA as a trusted technology partner and underlines its commitment to advancing global health through federated data analytics and artificial intelligence.
In the pre-market hours, SOPH is moving down 4.5 percent, to $3.15 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.